急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

陈坚; 王正东; 李平; 甘剑挺; 谢文超

doi:10.13898/j.cnki.issn.1000-2200.2017.09.009

急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

广西壮族自治区玉林市第一人民医院心内科, 537000

作者简介: 陈坚(1971-),男,硕士,副主任医师.

中图分类号: R692

Risk factor analysis of contrast-induced nephropathy in acute myocardial infarction patients treated with percutaneous coronary intervention

Department of Cardiology, The First People's Hospital of Yulin, Yulin Guangxi 537000, China
CLC number: R692

摘要: 目的：探讨急性心肌梗死病人经皮冠状动脉介入术（PCI）后发生对比剂肾病（CIN）的危险因素。方法：选取110例行急诊PCI治疗的急性心肌梗死病人，根据是否CIN分为CIN组和非CIN组，比较2组病人的一般资料、基础疾病、术前用药情况、对比剂使用情况等，分析CIN的危险因素。结果：2组病人的性别、年龄、体质量指数、血糖水平和血脂异常、高血压、既往心肌梗死、既往脑梗死例数差异均无统计学意义（P>0.05），而2组的肾功能不全、糖尿病、贫血例数和血清肌酐（SCr）、超敏C反应蛋白（hs-CRP）、血红蛋白水平及肾小球滤过率（eGFR）、左心室射血分数（LVEF）、肌酸激酶（CK）峰值、对比剂用量（CMV）差异均有统计学意义（P<0.05~P<0.01）。其中，肾功能不全、SCr、eGFR、CMV、CMV/eGFR和LVEF、hs-CRP、对糖尿病、贫血均为CIN的独立影响因素（P<0.05~P<0.01）。结论：除一般认为的肾功能不全、大剂量对比剂等危险因素外，糖尿病、高水平hs-CRP和CMV/eGFR等CIN危险因素也需引起足够重视。
- 对比剂肾病 /
- 经皮冠状动脉介入术 /
- 急性心肌梗死 /
- 肾功能 /
- 对比剂用量
Abstract: Objective: To study the related risk factors of contrast-induced nephropathy(CIN) of acute myocardial infarction(AMI) patients treated with percutaneous coronary intervention(PCI).Methods: One hundred and ten patients with AMI were treated with PCI,and divided into the CIN group and non-CIN group.The general information,underlying diseases,premedication and dosage of contrast agent between two groups were compared,and the risk factors of CIN were analyzed.Results: The differences of the gender,age,body mass index,blood sugar level,dyslipidemia,hypertension,myocardial infarction and cerebral infarction between two groups were not statistically significant(P>0.05).The differences of the renal insufficiency,diabetes,anemia,SCr,hs-CRP,eGFR,LVEF,CK and CMV between two groups were statistically significant(P<0.05 to P<0.01).The renal insufficiency,SCr,eGFR,CMV,CMV/eGFR,hs-CRP,LVEF,diabetes and anemia were the independent influencing factors of CIN(P<0.05 to P<0.01).Conclusions: The renal insufficiency and large dose of contrast agent are the risk factors of CIN,and the diabetes,high hs-CRP and CMV/eGFR also need to cause enough attention among the risk factors of CIN.
- contrast-induced nephropathy /
- percutaneous coronary intervention /
- acute myocardial infarction /
- kidney function /
- contrast agent dosage

[1]	TAKⅡ T,YASUDA S,TAKAHASHI J,et al.Trends in acute myocardial infarction incidence and mortality over 30 years in Japan:report from the MIYAGI-AMI Registry Study[J].Circ J,2010,74(1):93.
[2]	MARENZI G,ASSANELLI E,CAMPODONICO J,et al.Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality[J].Ann Intern Med,2009,150(3):170.
[3]	MCCULLOUGH PA.Contrast-induced acute kidney injury[J].J Am Coll Cardiol,2008,51(15):1419.
[4]	MARENZI G,ASSANELLI E,MARANA I,et al.N-acetylcysteine and contrast-induced nephropathy in primary angioplasty[J].N Engl J Med,2006,354(26):2773.
[5]	CHO JY,JEONG MH,HWAN PARK S,et al.Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure[J].J Cardiol,2010,56(3):300.
[6]	WATABE H,SATO A,HOSHI T,et al.Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention[J].Int J Cardiol,2014,174(1):57.
[7]	MERTEN GJ,BURGESS WP,RITTASE RA,et al.Prevention of contrast-induced nephropathy with sodium bicarbonate:an evidence-based protocol[J].Crit Pathw Cardiol,2004,3(3):138.
[8]	GOLDENBERG I,MATETZKY S.Nephropathy induced by contrast media:pathogenesis,risk factors and preventive strategies[J].CMAJ,2005,172(11):1461.
[9]	NOZUE T,MICHISHITA I,IWAKI T,et al.Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention[J].J Cardiol,2009,54(2):214.
[10]	MARENZI G,DE METRIO M,RUBINO M,et al.Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention[J].Am Heart J,2010,160(6):1170.
[11]	LIU Y,TAN N,ZHOU YL,et al.High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention[J].J Nephrol,2012,25(3):332.

[1]	吴浩龙 , 萧杰明 , 张美好 . 急性心肌梗死病人急诊PCI后发生对比剂肾病的危险因素分析. 蚌埠医学院学报, 2018, 43(8): 1022-1025. doi: 10.13898/j.cnki.issn.1000-2200.2018.08.013
[2]	李梦竹 , 王震寰 , 沈龙山 , 李成 , 李秀辉 . 急诊PCI与择期PCI对急性心肌梗死病人左心室功能的影响. 蚌埠医学院学报, 2018, 43(4): 437-439,443. doi: 10.13898/j.cnki.issn.1000-2200.2018.04.005
[3]	高伟 , 汪小五 , 高勇 . 充分水化联合精细化护理对预防经皮冠状动脉介入术后对比剂肾病的作用. 蚌埠医学院学报, 2019, 44(7): 963-965, 969. doi: 10.13898/j.cnki.issn.1000-2200.2019.07.033
[4]	吴纲 . 新活素对急性心肌梗死并发心力衰竭病人经皮冠状动脉介入术后预后的影响. 蚌埠医学院学报, 2022, 47(8): 1070-1073. doi: 10.13898/j.cnki.issn.1000-2200.2022.08.019
[5]	冯琴 , 许丽 , 郑桂香 , 赵培 , 焦云根 , 周艳 , 袁晓晨 , 朱莹 . 中青年急性心肌梗死病人冠状动脉介入术后应激障碍症状群的研究及干预策略. 蚌埠医学院学报, 2022, 47(5): 672-674. doi: 10.13898/j.cnki.issn.1000-2200.2022.05.029
[6]	竟雪莹 , 石增刚 , 张乐 , 解霞 . 静脉水化疗法预防经皮冠状动脉介入术后造影剂肾病. 蚌埠医学院学报, 2011, 36(7): 719-721.
[7]	周彤 , 周成超 , 唐碧 , 王洪巨 , 王莉媛 , 张晓玲 . 急性心肌梗死患者经皮冠状动脉介入术后自我管理水平的调查研究. 蚌埠医学院学报, 2016, 41(1): 126-129. doi: 10.13898/j.cnki.issn.1000-2200.2016.01.041
[8]	查秀婧 , 邵晨 , 马续祥 . 外周血高密度脂蛋白水平与糖尿病肾病病人炎性指标、肾功能及胰岛素抵抗的关系. 蚌埠医学院学报, 2022, 47(4): 491-495. doi: 10.13898/j.cnki.issn.1000-2200.2022.04.016
[9]	谢伟 , 袁争百 , 苏振琪 , 韩宏华 , 陈大顺 . 急性ST段抬高型心肌梗死经皮冠状动脉介入开通闭塞血管时间的影响因素. 蚌埠医学院学报, 2015, 40(3): 372-374. doi: 10.13898/j.cnki.issn.1000-2200.2015.03.026
[10]	黄丹 , 胡韬韬 , 陈丹 . 血清高迁移率族蛋白B1与糖尿病肾病病人肾功能、炎症因子及氧化应激指标的相关性研究. 蚌埠医学院学报, 2022, 47(8): 1021-1025. doi: 10.13898/j.cnki.issn.1000-2200.2022.08.008
[11]	陈天平 , 张乃菊 , 谢彩侠 , 李妙男 , 耿旭 , 胡司淦 , 刘进军 , 唐碧 . 不同年龄段急性心肌梗死病人临床和冠状动脉病变特点分析. 蚌埠医学院学报, 2020, 45(10): 1351-1354. doi: 10.13898/j.cnki.issn.1000-2200.2020.10.010
[12]	张芳 . ACEI联合AT1受体阻断剂双重阻断RAS系统治疗老年糖尿病肾病疗效分析. 蚌埠医学院学报, 2020, 45(1): 74-77. doi: 10.13898/j.cnki.issn.1000-2200.2020.01.019
[13]	李玉忠 , 吴霭青 . 不同剂量右美托咪定用于急性冠状动脉综合征PCI介入效果分析. 蚌埠医学院学报, 2016, 41(5): 616-618. doi: 10.13898/j.cnki.issn.1000-2200.2016.05.020
[14]	余强 , 张大东 . 曲美他嗪对冠状动脉介入术后心肌缺血再灌注损伤的保护作用研究. 蚌埠医学院学报, 2012, 36(4): 418-421.
[15]	胡擎天 , 王月祥 , 曾超超 , 李静 , 耿志军 , 刘进军 . 血清MAL蛋白水平和急性冠状动脉综合征的相关性研究. 蚌埠医学院学报, 2023, 48(10): 1383-1386. doi: 10.13898/j.cnki.issn.1000-2200.2023.10.012
[16]	竟雪莹 , 祖磊 . 不同剂量阿托伐他汀对急性冠状动脉综合征患者PCI术后炎症因子的影响. 蚌埠医学院学报, 2013, 37(9): 1103-1104,1107.
[17]	葛玲 , 程训民 , 毛诗海 , 崔杰西 , 张琪 , 纪杨 . 血清胱抑素C测定在肾病早期诊断中的应用. 蚌埠医学院学报, 2011, 36(12): 1382-1384.
[18]	马丹 , 高振宇 . 贝前列素钠联合环磷酰胺治疗肾病综合征病人的短、中期随访研究. 蚌埠医学院学报, 2020, 45(3): 355-359, 362. doi: 10.13898/j.cnki.issn.1000-2200.2020.03.019
[19]	吴纲 , 李雪冬 , 曹超 , 王真 , 邵胜胜 , 胡业梅 . 新活素前置应用对急性心肌梗死急诊PCI病人预后影响的临床研究. 蚌埠医学院学报, 2023, 48(9): 1211-1214. doi: 10.13898/j.cnki.issn.1000-2200.2023.09.007
[20]	焦红玉 . 时间护理对急性心肌梗死患者临床症状及心理状态的影响. 蚌埠医学院学报, 2016, 41(5): 692-694. doi: 10.13898/j.cnki.issn.1000-2200.2016.05.047

点击查看大图

计量

文章访问数: 3635
HTML全文浏览量: 422
PDF下载量: 94
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

作者简介: 陈坚(1971-),男,硕士,副主任医师.

Risk factor analysis of contrast-induced nephropathy in acute myocardial infarction patients treated with percutaneous coronary intervention

计量

急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

作者简介: 陈坚(1971-),男,硕士,副主任医师.

English Abstract

Risk factor analysis of contrast-induced nephropathy in acute myocardial infarction patients treated with percutaneous coronary intervention

全文HTML

目录

留言板

急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

作者简介: 陈坚(1971-),男,硕士,副主任医师.

Risk factor analysis of contrast-induced nephropathy in acute myocardial infarction patients treated with percutaneous coronary intervention

计量

出版历程

急性心肌梗死病人经皮冠状动脉介入术后对比剂肾病的危险因素分析

作者简介: 陈坚(1971-),男,硕士,副主任医师.

English Abstract

Risk factor analysis of contrast-induced nephropathy in acute myocardial infarction patients treated with percutaneous coronary intervention

全文HTML

目录